In the combination therapy of crocin and cisplatin in human gastric cancer cells (BGC-823), the cancer cell proliferation was suppressed and the apoptosis was promoted (Luo et al., 2017), which may result from the increased expression of p53 and Bax and decreased expression of Bcl-2 in BGC-823 cells. The gene discussed is BCL2; the disease is cancer.